MIR7702

Across TCGA pan-cancer cohorts, MIR7702 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR7702 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR7702 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR7702 expression acts as an unfavorable survival marker.

BLCA, DLBC, and PAAD are the cancer types where MIR7702 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.132	0.720	<.001	126	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	54	view →
PAAD	OS	Tertile	All	0.037	0.641	<.001	45	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
ESCA	DFS	Tertile	II,III,IV	0.227	0.531	.013	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR7702–BLCA (OS)

Open the BLCA breakdown →